Tristel (TSTL) Share Price, News & Analysis

Company Overview

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

Key Stats

• Today's Range: 370 to 385
• 50-Day Range: 355 to 420.84
• 52-Week Range: 340 to 445
• Volume: 1.24 million shs
• Average Volume: 158,692 shs
• Market Capitalization: £183.34 million
• P/E Ratio: 23.55
• Dividend Yield: 3.74%
• Price Target: GBX 400
• Consensus Rating: Hold

Tristel Stock Analysis - MarketRank™

Tristel scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

Tristel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for Tristel is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Tristel has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tristel is 23.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tristel is 23.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.63.

Price to Book Value per Share Ratio

Tristel has a P/B Ratio of 5.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for TSTL.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Tristel is a leading dividend payer. It pays a dividend yield of 3.74%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Tristel does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Tristel is 87.44%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Tristel this week, compared to 0 articles on an average week.

Company Ownership

• Score: 3.8 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net £18,906.44 in company stock, which represents 0.0103% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Tristel insiders have bought more of their company's stock than they have sold. Specifically, they have bought £18,906.44 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

21.03% of the stock of Tristel is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

21.95% of the stock of Tristel is held by institutions.

Company Calendar

• Last Earnings: 3/02/2026
• Today: 5/31/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: LON:TSTL
• CIK: N/A
• Web: www.tristel.com
• Phone: +44-1638-721500
• Fax: N/A
• Employees: 208
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Tristel: GBX 400
• High Price Target: GBX 400
• Low Price Target: GBX 400
• Potential Upside/Downside: +4.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 16.24
• Trailing P/E Ratio: 23.55
• Forward P/E Ratio: 23.47
• P/E Growth: N/A
• Net Income: £6.54 million
• Net Margins: 15.88%
• Pretax Margin: N/A
• Return on Equity: 23.64%
• Return on Assets: 9.89%

Debt

• Debt-to-Equity Ratio: 17.36
• Current Ratio: 4.13
• Quick Ratio: 3.83

Sales & Book Value

• Annual Sales: £49.54 million
• Price / Sales: 3.70
• Cash Flow: GBX 18.25 per share
• Price / Cash Flow: 20.96
• Book Value: GBX 68.34 per share
• Price / Book: 5.60

Miscellaneous

• Outstanding Shares: 47,932,000
• Free Float: N/A
• Market Cap: £183.34 million
• Optionable: Not Optionable
• Beta: 0.34